Tracking rule reminder
This article was originally published in The Gray Sheet
Executive Summary
Joseph Levitt, the FDA device center's deputy director for regulations and policy, sends industry associations a reminder letter on FDA's tracking rule pointing out that the rule became final on Nov. 29 and will be effective Aug. 29. Levitt also informs the associations that the center is preparing a question and answer document for manufacturers that will "respond to many of the most prevalent concerns about device tracking." FDA decided to send the reminder letter because it has been slow in issuing a Federal Register notice that would formally announce the finalization of the rule and clarify some of its provisions ("The Gray Sheet" Nov. 2, p. 4).
You may also be interested in...
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.
Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing
Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.